These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Letter: Combination of a dopa decarboxylase inhibitor with 5-hydroxytryptophan therapy]. Lhermitte F; Degos CF; Marteau R Nouv Presse Med; 1975 Jan; 4(1):31. PubMed ID: 1079935 [No Abstract] [Full Text] [Related]
5. Spinal myoclonus: successful treatment with the combination of sodium valproate and L-5-hydroxytryptophan. Jiménez-Jiménez FJ; Roldan A; Zancada F; Molina-Arjona JA; Fernandez-Ballesteros A; Santos J Clin Neuropharmacol; 1991 Apr; 14(2):186-90. PubMed ID: 2015615 [TBL] [Abstract][Full Text] [Related]
6. Clinical and metabolic observations on the treatment of myoclonus with L-5-HTP and carbidopa. Thal L; Sharpless N; Wolfson L; Engel J; Katzman R Trans Am Neurol Assoc; 1976; 101():48-52. PubMed ID: 1088459 [No Abstract] [Full Text] [Related]
7. [Case of intention myoclonus (Lance-Adams syndrome) and a dramatic effect of L-5-hydroxytryptophan]. Satoyoshi E; Kinoshita M; Takazawa Y; Yoda K Rinsho Shinkeigaku; 1976 Sep; 16(9):654-60. PubMed ID: 1087598 [No Abstract] [Full Text] [Related]
8. L-5-hydroxytryptophan in treatment of several different syndromes in which myoclonus is prominent. Growdon JH; Young RR; Shahani BT Neurology; 1976 Dec; 26(12):1135-40. PubMed ID: 1086988 [TBL] [Abstract][Full Text] [Related]
9. Successful treatment of cherry red spot-myoclonus syndrome with 5-hydroxytryptophan. Gascon G; Wallenberg B; Daif AK; Ozand P Ann Neurol; 1988 Sep; 24(3):453-5. PubMed ID: 3265864 [TBL] [Abstract][Full Text] [Related]
10. L-5 HTP available under treatment IND. FDA Drug Bull; 1983 Aug; 13(2):12-3. PubMed ID: 6604672 [No Abstract] [Full Text] [Related]
11. The effect of intravenous L-5-HTP in the myoclonic encephalopathy of infants. Gobbi G; Melideo G; Giovanardi Rossi P Neuropediatrics; 1986 May; 17(2):63-5. PubMed ID: 3014368 [TBL] [Abstract][Full Text] [Related]
12. Post-hypoxic intention myoclonus treated with 5-hydroxy-tryptophan and an extracerebral decarboxylase inhibitor. Magnussen I; Dupont E; Engbaek F; de Fine Olivarius B Acta Neurol Scand; 1978 Apr; 57(4):289-94. PubMed ID: 307327 [TBL] [Abstract][Full Text] [Related]
13. Myoclonus. Marsden CD Mod Trends Neurol; 1975; 6():321-2. PubMed ID: 1105145 [No Abstract] [Full Text] [Related]
14. Myoclonus, ataxia, and hypoventilation: response to L-5-hydroxytryptophan. Feit H; Kirkpatrick J; Van Woert MH; Pandian G Neurology; 1983 Jan; 33(1):109-12. PubMed ID: 6600288 [No Abstract] [Full Text] [Related]
15. [Indications for L-5-hydroxytryptophan in neurology]. Uldry PA; Regli F Rev Med Suisse Romande; 1987 Sep; 107(9):703-7. PubMed ID: 2962265 [No Abstract] [Full Text] [Related]